Director, Molecular Pathology, Translational Sciences, Translational Research.
Revolution Medicines · Redwood City, CA
RoleLantern re-checked this role's application link recently and it was active — the employer has not confirmed it directly.
Role summary
Revolution Medicines seeks a Director of Molecular Pathology to lead biomarker strategy and spatial technology implementation within its Translational Sciences group. The role focuses on developing and executing molecular pathology-driven biomarker strategies for RAS-targeted oncology programs, bridging translational research with clinical development.
What they're looking for
- 10+ years in digital pathology or spatial biology in pharma, biotech, or CRO
- Deep knowledge of spatial biology platforms (Visium, Xenium, GeoMx, MerFish, etc.)
- PhD or MD in Cancer Biology, Translational Sciences, Pathology, or related field
- Ability to translate complex spatial datasets into actionable scientific insights
- Strong cross-functional collaboration and external partner management experience
- Expertise in whole-slide imaging, AI/ML-based image analysis, and data quality standards
What you'll be doing
- Define and execute molecular and digital pathology-driven biomarker strategies for RAS(ON) inhibitor programs
- Perform and interpret multiplex spatial biomarker datasets to inform translational hypotheses and clinical development strategies
- Serve as primary scientific liaison to CROs for spatial biomarker workflows and quality oversight
- Lead adoption of spatial technologies and establish quality control standards for data acquisition and analysis
- Collaborate with Translational Medicine, Bioinformatics, and Clinical Development on candidate biomarker implementation
Privacy & handoff
This role links to Revolution Medicines's own application system. RoleLantern records your interest and checks the link, but the application happens on the employer's site and status updates may not come back to us. Clicking apply does not mark you as applied automatically.